NEW YORK – Sema4 and artificial intelligence informatics company VieCure announced a collaboration to enable personalized cancer care research and streamline access to genetic testing and clinical trials.
Under the partnership, Sema4 scientists conducting cancer diagnosis, treatment, and prevention research can access data that patients have agreed to share on the VCurePrecision EMR platform and build predictive models using Sema4's Centrellis health intelligence platform.